The KYMAB brand, founded in 2010 (United Kingdom), from 2757 sister brands and 17477 competing brands. The KYMAB brand is owned by Sanofi, a company listed in Paris. The ISIN, the company's International Securities Identification Number, is FR0000120578. KYMAB belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Sanofi
(KYMAB)
over 5 years*
EUR 107.32